Antitumor activity of dichloroacetate on C6 glioma cell: in vitro and in vivo evaluation
Authors:
Open Access
- 1 March 2013
- journal article
- research article
- Published by Taylor & Francis in OncoTargets and Therapy
- Vol. 6, 189-198
Abstract
Dichloroacetate (DCA), a small molecule mitochondria-targeting agent, can penetrate the blood–brain barrier, showing potential therapeutic effects on brain tumors. Considering the effects of DCA on tumor cellular metabolism, penetrating across the blood–brain barrier, as well as having potential antitumor activity on brain tumors, the purpose of this study is to investigate the antitumor activity of DCA on C6 glioma cells in vitro and in vivo. DCA inhibited C6 glioma cell proliferation, induced C6 cell apoptosis, and arrested C6 cells in S phase. DCA can inhibit the expression of heat shock proteins 70 (Hsp70) in a dose-dependent and time-dependent manner (P < 0.01). Our in vivo antitumor effect results indicated that DCA markedly inhibited the growth of C6 glioma tumors in both C6 brain tumor-bearing rats and C6 tumor-bearing nude mice (P <0.01). DCA significantly induced the ROS production and decreased the mitochondrial membrane potential in tumor tissues. Our in vivo antitumor effect results also indicated that DCA has potential antiangiogenic effects. In conclusion, DCA may be a viable therapeutic agent in the treatment of gliomas.Keywords
This publication has 46 references indexed in Scilit:
- Polyethyleneimine-modified iron oxide nanoparticles for brain tumor drug delivery using magnetic targeting and intra-carotid administrationBiomaterials, 2010
- Dichloroacetate induces apoptosis and cell-cycle arrest in colorectal cancer cellsBritish Journal of Cancer, 2010
- A new alternative mechanism in glioblastoma vascularization: tubular vasculogenic mimicryBrain, 2010
- Targeting the Warburg effect in hematological malignancies: from PET to therapyCurrent Opinion in Oncology, 2009
- Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancerBritish Journal of Cancer, 2008
- Dichloroacetate induces apoptosis in endometrial cancer cellsGynecologic Oncology, 2008
- The 2007 WHO Classification of Tumours of the Central Nervous SystemActa Neuropathologica, 2007
- Metabolic targeting of hypoxia and HIF1 in solid tumors can enhance cytotoxic chemotherapyProceedings of the National Academy of Sciences, 2007
- Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trialThe Lancet Oncology, 2006
- On the Origin of Cancer CellsScience, 1956